Terms: = Ovarian cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG
442 results:
1. GT-00AxIL15, a Novel Tumor-Targeted IL-15-Based Immunocytokine for the Treatment of TA-muc1-Positive Solid Tumors: Preclinical In Vitro and In Vivo Pharmacodynamics and Biodistribution Studies.
Gellert J; Jäkel A; Danielczyk A; Goletz C; Lischke T; Flechner A; Dix L; Günzl A; Kehler P
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338686
[TBL] [Abstract] [Full Text] [Related]
2. An Aptamer-Based Nanoflow Cytometry Method for the Molecular Detection and Classification of ovarian cancers through Profiling of Tumor Markers on Small Extracellular Vesicles.
Li J; Li Y; Li Q; Sun L; Tan Q; Zheng L; Lu Y; Zhu J; Qu F; Tan W
Angew Chem Int Ed Engl; 2024 Jan; 63(4):e202314262. PubMed ID: 38012811
[TBL] [Abstract] [Full Text] [Related]
3. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
[TBL] [Abstract] [Full Text] [Related]
4. Undifferentiated component of dedifferentiated endometrial carcinoma presenting as a "small round cell" malignancy in a mediastinal lymph node, mimicking small cell carcinoma.
Balikani L; Policarpio-Nicolas MLC
Diagn Cytopathol; 2023 Aug; 51(8):519-524. PubMed ID: 37318779
[TBL] [Abstract] [Full Text] [Related]
5. Uterine choriocarcinoma coexistence with endometroid adenocacinoma: a case report and literature review.
Bai L; Chen Y; Han L; Zheng A; Mo X
BMC Womens Health; 2023 May; 23(1):252. PubMed ID: 37165420
[TBL] [Abstract] [Full Text] [Related]
6. CREB fusion-associated epithelioid mesenchymal neoplasms of the female adnexa: three cases documenting a novel location of an emerging entity and further highlighting an ambiguous misleading immunophenotype.
Trecourt A; Macagno N; Ngo C; Philip CA; Lopez J; Ferreira J; Alves-Vale C; Ray-Coquard I; Genestie C; Agaimy A; Devouassoux-Shisheboran M
Virchows Arch; 2023 Jun; 482(6):967-974. PubMed ID: 37097347
[TBL] [Abstract] [Full Text] [Related]
7. Bioinformatic analysis confirms differences in circular RNA expression profiles of cumulus cells between patients with ovarian and peritoneal endometriosis-associated infertility.
Huang X; Yu Q
Front Endocrinol (Lausanne); 2023; 14():1137235. PubMed ID: 37008951
[TBL] [Abstract] [Full Text] [Related]
8. Real-World Data on Olaparib in Relapsed BRCA-mutated ovarian cancer: A Multicenter GINECO RETROLA Cohort Study.
Bourien H; Lefevre LB; Mouret-Reynier MA; Asselain B; Lucas B; Gavoille C; Cornila C; Gavoille L; Colomba E; Patsouris A; Fabbro M; Chakiba C; Toussaint P; Simon H; Berton D; Garbay D; Tixidre CG; Coeffic D; Morvan A; Collard O; DE LA Motte Rouge T
Anticancer Res; 2023 Feb; 43(2):653-662. PubMed ID: 36697069
[TBL] [Abstract] [Full Text] [Related]
9. Targeted Delivery of Sunitinib by MUC-1 Aptamer-Capped Magnetic Mesoporous Silica Nanoparticles.
Torabi M; Aghanejad A; Savadi P; Barzegari A; Omidi Y; Barar J
Molecules; 2023 Jan; 28(1):. PubMed ID: 36615606
[TBL] [Abstract] [Full Text] [Related]
10. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
[TBL] [Abstract] [Full Text] [Related]
11. Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat ovarian cancer.
Li Z; Liu Q; Zhu Y; Wu L; Liu W; Li J; Zhang Z; Tao F
Oxid Med Cell Longev; 2022; 2022():2896049. PubMed ID: 36062197
[TBL] [Abstract] [Full Text] [Related]
12. Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial ovarian cancer.
Revythis A; Limbu A; Mikropoulos C; Ghose A; Sanchez E; Sheriff M; Boussios S
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886427
[TBL] [Abstract] [Full Text] [Related]
13. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
[TBL] [Abstract] [Full Text] [Related]
14. Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination.
Kahn RM; Ragupathi G; Zhou QC; Iasonos A; Kravetz S; Hensley ML; Konner JA; Makker V; Tew WP; Aghajanian C; Sabbatini PJ; O'Cearbhaill RE
Cancer Immunol Immunother; 2023 Jan; 72(1):183-191. PubMed ID: 35779095
[TBL] [Abstract] [Full Text] [Related]
15. Diagnostic potential of nanoparticle aided assays for muc16 and muc1 glycovariants in ovarian cancer.
Jain S; Nadeem N; Ulfenborg B; Mäkelä M; Ruma SA; Terävä J; Huhtinen K; Leivo J; Kristjansdottir B; Pettersson K; Sundfeldt K; Gidwani K
Int J Cancer; 2022 Oct; 151(7):1175-1184. PubMed ID: 35531590
[TBL] [Abstract] [Full Text] [Related]
16. pumILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and contributes to ovarian cancer progression.
Li X; Zhu M; Zang M; Cao D; Xie Z; Liang H; Bian Z; Zhao T; Hu Z; Xu EY
Cell Mol Life Sci; 2022 May; 79(5):279. PubMed ID: 35507203
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological observation of mature teratoma with malignant transformation, a single center retrospective study.
Yuan Y; Li H; Yang H
Indian J Pathol Microbiol; 2022; 65(2):369-373. PubMed ID: 35435373
[TBL] [Abstract] [Full Text] [Related]
18. Endocrine cell micronests in an ovarian mucinous borderline tumor: a potential diagnostic pitfall for microinvasion.
Collins K; Segura S; Hwang M
Diagn Pathol; 2022 Apr; 17(1):37. PubMed ID: 35422044
[TBL] [Abstract] [Full Text] [Related]
19. Endometrial giant cell carcinoma: new insights from a morphological, immunohistochemical, and molecular analysis of three cases.
Arciuolo D; Travaglino A; Raffone A; Santoro A; Russo G; Minucci A; Inzani F; Mollo A; Pedone Anchora L; Fanfani F; Insabato L; Zannoni GF
Virchows Arch; 2022 Aug; 481(2):321-326. PubMed ID: 35305145
[TBL] [Abstract] [Full Text] [Related]
20. A combination of immunohistochemical markers, muc1, MUC5AC, PAX8 and growth pattern for characterization of mucinous neoplasm of the ovary.
Chelariu-Raicu A; Holley E; Mayr D; Klauschen F; Wehweck F; Rottmann M; Kessler M; Kaltofen T; Czogalla B; Trillsch F; Mahner S; Schmoeckel E
Int J Gynecol Cancer; 2022 May; 32(5):662-668. PubMed ID: 35185017
[TBL] [Abstract] [Full Text] [Related]
[Next]
